Dual regulating effects of gastrodin on extracellular dopamine concentration in rats models of Tourette's syndrome

References

• Leckman JF. Tourette's syndrome. Lancet 2002;360:1577–86.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Leckman JF. Clinical course of Tourette's syndrome. J Psychosom Res 2009;67:497–501.
   PubMed Web of Science ®Google Scholar
• Hornse H, Banerjee S, Zeitlin H, et al. The prevalence of Tourette syndrome in 13-14-year-olds in mainstream schools. J Child Psychol Psychiatry 2001;42:1035–39.
   PubMed Web of Science ®Google Scholar
• Stern JS, Burza S. Robertson MM. Gilles de la Tourette's syndrome and its impact in the UK. Postgrad Med J 2005;81: 12–19.
   PubMed Web of Science ®Google Scholar
• Berthier ML, Campos VM, Kulisevsky J, et al. Heroin and malignant coprolalia in Tourette's syndrome. J Neuropsych Clin Neurosci 2003;15:116–17.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Cham R. Postural control, gait, and dopamine functions in parkinsonian movement disorders. Clin Geriatr Med 2006;22:797–12.
   PubMed Web of Science ®Google Scholar
• Schultz W. Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 1997;7:191–197.
   PubMed Web of Science ®Google Scholar
• Staller JA, Faraone SV. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother 2007;7:351–62.
   PubMedGoogle Scholar
• Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007;30:259–88.
   PubMed Web of Science ®Google Scholar
• Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978;179:641–67.
   PubMed Web of Science ®Google Scholar
• Gurevich EV, Joyce JN. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain. Neuropsychopharmacol 1996;14:309–23.
   PubMed Web of Science ®Google Scholar
• Aldridge J, Berridge KC. Coding of serial order by neostriatal neurorons: a “natural action” approach to movement sequences. J Neurosci 1998;18:2777–87.
   PubMed Web of Science ®Google Scholar
• Mink JW. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatr Neurol 2001;25:190–98.
   PubMed Web of Science ®Google Scholar
• Albin RL, Mink JW. Recent advances in Tourette's syndrome research. Trends Neurosci 2006;29:175–82.
   PubMed Web of Science ®Google Scholar
• Mink J. The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol 2003;60:1365–68.
   PubMed Web of Science ®Google Scholar
• Seignot JN. Un cas de maladie des tics de Gilles de la Tourette guéri par le R.1625. Annales Médico-Psychologiques 1961;119:578–79.
   PubMedGoogle Scholar
• Hartmann A, Worbe Y. Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013; 37: 1157–61.
   PubMed Web of Science ®Google Scholar
• Singer HS, Rabins P, Coyle JT. Serum haloperidol levels in Gilles de la Tourette's syndrome. Biol Psychiat 1981;16:79–84.
   PubMed Web of Science ®Google Scholar
• Wolf SS, Jones DW, Knable MB, et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996;273:1225–27.
   PubMed Web of Science ®Google Scholar
• Minzer K, Lee O, Hong JJ, et al. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum. J Neurol Sci 2004;219:55–61.
   PubMed Web of Science ®Google Scholar
• Wong DF, Brasic JR, Singer HS, et al. Mechanisms of dopaminergic and serotonergic neurotrans-mission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacol 2008;33:1239–51.
   PubMed Web of Science ®Google Scholar
• Steeves TD, Ko JH, Kideckel DM, et al. Extrastriatal dopaminergic dysfunction in Tourette syndrome. Ann Neurol 2010;67:170–81.
   PubMed Web of Science ®Google Scholar
• Turjanski N, Sawle GV, Playford ED, et al. Pet Studies of the Presynaptic and Postsynaptic Dopaminergic System in Tourette's Syndrome. J Neurol Neurosur Ps 1994;57:688–92.
   PubMed Web of Science ®Google Scholar
• Stamenkovic M, Schindler SD, Asenbaum S, No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study. Eur Neuropsychopharmacol 2001;11:69–74.
   PubMed Web of Science ®Google Scholar
• Steeves TD, Fox SH. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 2008;172:495–507.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Dure L, Sethuraman G, et al. Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003;60:606–611.
   Google Scholar
• Wong DF, Brasic JR, Singer HS, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacol 2008;33:1239–51.
   PubMed Web of Science ®Google Scholar
• Malison RT, McDougle CJ, van Dyck CH.[123I]β–CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 1995;152:1359–61.
   PubMed Web of Science ®Google Scholar
• Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: Structure, regulation and function. Nat Rev Neurosci 2003;4:13–25.
   PubMed Web of Science ®Google Scholar
• Randrup A, Munkvad I, Udsen P. Adrenergic mechanisms and amphetamine induced abnormal behaviour. Acta Pharmacol Toxicol 1963;20:145–57.
   PubMedGoogle Scholar
• Diamond BI, Reyes MG, Borison R. A new animal model for Tourette syndrome. Adv Neurol 1982;35:221–25.
   PubMedGoogle Scholar
• Hirata H, Ogawa N, Asanuma M, et al. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. Brain Res 1993;604:197–204.
   PubMed Web of Science ®Google Scholar
• Lv H, Li A, Ma H, et al. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. J Ethnapharmacol 2009;124:488–92.
   PubMed Web of Science ®Google Scholar
• Sun W, Miao B, Wang X, et al. Gastrodin inhibits allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing excitability of nociceptive primary sensory neurons. PLoS one 2012;7:e39647.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen G, Zeng S. Distribution and metabolism of gastrodin in rat brain. J Pharm Biomed Anal 2008;46:399–404.
   PubMed Web of Science ®Google Scholar
• An S, Park S, Hwang I, et al. Gastrodin decreases immunoreactivities of gamma-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils. J Neurosci Res 2003;71:534–43.
   PubMed Web of Science ®Google Scholar
• Dai J, Zong Y, Zhong L, et al. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS one 2011;6:21891.
   PubMed Web of Science ®Google Scholar
• Manavalan A, Ramachandran U, Sundaramurthi H, et al. Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities. Int J Biochem Mol Biol 2012;3:219–41.
   PubMedGoogle Scholar
• Lv H, Li A, Ma H, et al. Effects of gastrodin on the dopamine system of Tourette's syndrome rat models. BioScience Trends 2009;3:58–62.
   PubMedGoogle Scholar
• Wakata N, Araki Y, Sugimoto H, et al. IDPN-induced monoamine and Hydroxyl radical changes in the rat brain. Neurochem Res 1999;25:401–4.
   Web of Science ®Google Scholar
• Napier TC, Istre ED. Methamphetamine-induced sensitization includes a functional up-regulation of ventral pallidal 5-HT2A/2C receptors. Synapse 2008;62:14–21.
   PubMed Web of Science ®Google Scholar
• Wei LL, Chen H, Zhong M, et al. HPLC-ECD determination of on striatal extracellular levels of monoamine neurotransmitter. Chin J Pharmacol Anal 2011;3:467–70.
   Google Scholar
• Tariq M, Khan H, Al Moutaery K, et al. Attenuation of iminodipropionitrile induced behavioral syndrome by sodium salicylate in rats. Pharmacol Biochem Behav 2002;73:647–54.
   PubMed Web of Science ®Google Scholar
• Hertting G, Axelrod J. Fate of tritiated noradrenaline at the sympathetic nerve endings. Nature 1961;192:172–73.
   PubMed Web of Science ®Google Scholar